Kamada (KMDA) EPS (Diluted) Growth (1y) (2016 - 2026)
Kamada (KMDA) EPS (Diluted) Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 65.33% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 5.88% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -394.16% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.15% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 105.88% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,383.26% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -16.09% |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -28.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.85% |
| Dec 31, 2025 | 427.25% |
| Sep 30, 2025 | 71.30% |
| Jun 30, 2025 | 29.06% |
| Mar 31, 2025 | 242.16% |
| Dec 31, 2024 | -79.35% |
| Sep 30, 2024 | 4.52% |
| Jun 30, 2024 | -99.79% |
| Mar 31, 2024 | 116,192.41% |
| Dec 31, 2023 | 28.43% |
| Sep 30, 2023 | 537,609.95% |
| Jun 30, 2023 | -54.03% |
| Mar 31, 2023 | -100.10% |
| Dec 31, 2022 | 167.45% |
| Sep 30, 2022 | -99.93% |
| Jun 30, 2022 | 306.07% |
| Mar 31, 2022 | -32.40% |
| Dec 31, 2021 | -393.77% |
| Sep 30, 2021 | -88.44% |
| Jun 30, 2021 | -74.60% |